SEC 13F Intelligence

Highvista Strategies LLC / TARS

Highvista Strategies LLC’s Tarsus Pharmaceuticals Inc Position

Does Highvista Strategies LLC own Tarsus Pharmaceuticals Inc (TARS)? Yes — 52.5K shares worth $4M (+1.02% of its 13F portfolio) as of Q1 2026, down from 53.6K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
52.5K
% of Portfolio
+1.02%
Quarters Held
5
currently held

Position History TARS

Reported value by quarter
Q1 ’21: $680,000Q1 ’21Q2 ’25: $473,157Q2 ’25Q3 ’25: $1MQ3 ’25Q4 ’25: $4MQ4 ’25Q1 ’26: $4MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202652.5K$4M+1.02%
Q4 202553.6K$4M+1.13%
Q3 202524.9K$1M+0.36%
Q2 202511.7K$473,157+0.17%
Q1 202121.1K$680,000+0.51%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of TARS.